(Q84275685)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Marcelo Lima Ribeiro

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

H M Andrade

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

V P C P Toledo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

M B Pinheiro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

T M P D Guimarães

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

N C Oliveira

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

J A Castro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

R N Silva

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

A C Amorim

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

M Yoko

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

A S Silva

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

K Dumont

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

W Bartchewsky

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

S J H Monte

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

14 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

published in

Veterinary Parasitology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

2-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

83-90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

Distribution and relationships between clinical and biopathological parameters in canine leishmaniasis.

3 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Antiprotozoal activities of phospholipid analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Rapid clearance of circulating Leishmania kinetoplast DNA after treatment of visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

The immunopathology of experimental visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Leishmania DNA quantification by real-time PCR in naturally infected dogs treated with miltefosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Interferon-gamma (INF-gamma), IL4 expression levels and Leishmania DNA load as prognostic markers for monitoring response to treatment of leishmaniotic dogs with miltefosine and allopurinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Incidence and time course of Leishmania infantum infections examined by parasitological, serologic, and nested-PCR techniques in a cohort of naive dogs exposed to three consecutive transmission seasons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Polymerase chain reaction with two molecular targets in mucosal leishmaniasis' diagnosis: a validation study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Leishmania DNA is rapidly degraded following parasite death: an analysis by microscopy and real-time PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Quantification of Leishmania infantum parasites in tissue biopsies by real-time polymerase chain reaction and polymerase chain reaction-enzyme-linked immunosorbent assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Real-time PCR in clinical practice: a powerful tool for evaluating Leishmania chagasi loads in naturally infected dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Treatment of Bolivian mucosal leishmaniasis with miltefosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Trial of oral miltefosine for visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Long term improvement in the treatment of canine leishmaniosis using an antimony liposomal formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Immunopathogenesis of infection with the visceralizing Leishmania species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

Clinical efficacy and tolerance of miltefosine in the treatment of canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.009

10.1016/J.VETPAR.2011.05.009

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21641721%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference